Insulin-Like Growth Factor Binding Protein 3

"Insulin-Like Growth Factor Binding Protein 3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

One of the six homologous soluble proteins that bind insulin-like growth factors (SOMATOMEDINS) and modulate their mitogenic and metabolic actions at the cellular level.

Descriptor ID	D018972
MeSH Number(s)	D12.776.157.420.270
Concept/Terms	Insulin-Like Growth Factor Binding Protein 3 Insulin-Like Growth Factor Binding Protein 3 IGF-Binding Protein 3 IGF Binding Protein 3 Protein 3, IGF-Binding IGFBP-3

Below are MeSH descriptors whose meaning is more general than "Insulin-Like Growth Factor Binding Protein 3".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Carrier Proteins [D12.776.157]
Insulin-Like Growth Factor Binding Proteins [D12.776.157.420]
Insulin-Like Growth Factor Binding Protein 3 [D12.776.157.420.270]

Below are MeSH descriptors whose meaning is related to "Insulin-Like Growth Factor Binding Protein 3".

Below are MeSH descriptors whose meaning is more specific than "Insulin-Like Growth Factor Binding Protein 3".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Insulin-Like Growth Factor Binding Protein 3" by people in this website by year, and whether "Insulin-Like Growth Factor Binding Protein 3" was a major or minor topic of these publications.

Bar chart showing 20 publications over 12 distinct years, with a maximum of 3 publications in 2004

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	0	1	1
2003	0	2	2
2004	2	1	3
2005	2	0	2
2006	1	1	2
2007	2	0	2
2010	0	2	2
2011	0	1	1
2015	1	1	2
2016	0	1	1
2017	1	0	1
2023	0	1	1

Below are the most recent publications written about "Insulin-Like Growth Factor Binding Protein 3" by people in Profiles.

Charlton JR, Li T, Wu T, deRonde K, Xu Y, Baldelomar EJ, Bennett KM. Use of novel structural features to identify urinary biomarkers during acute kidney injury that predict progression to chronic kidney disease. BMC Nephrol. 2023 06 19; 24(1):178.

View in: PubMed
H?sing A, Fortner RT, K?hn T, Overvad K, Tj?nneland A, Olsen A, Boutron-Ruault MC, Severi G, Fournier A, Boeing H, Trichopoulou A, Benetou V, Orfanos P, Masala G, Pala V, Tumino R, Fasanelli F, Panico S, Bueno de Mesquita HB, Peeters PH, van Gills CH, Quir?s JR, Agudo A, S?nchez MJ, Chirlaque MD, Barricarte A, Amiano P, Khaw KT, Travis RC, Dossus L, Li K, Ferrari P, Merritt MA, Tzoulaki I, Riboli E, Kaaks R. Added Value of Serum Hormone Measurements in Risk Prediction Models for Breast Cancer for Women Not Using Exogenous Hormones: Results from the EPIC Cohort. Clin Cancer Res. 2017 Aug 01; 23(15):4181-4189.

View in: PubMed
Merritt MA, Strickler HD, Einstein MH, Yang HP, Sherman ME, Wentzensen N, Brouwer-Visser J, Cossio MJ, Whitney KD, Yu H, Gunter MJ, Huang GS. Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors. Cancer Causes Control. 2016 06; 27(6):737-48.

View in: PubMed
Chung S, Dwabe S, Elshimali Y, Sukhija H, Aroh C, Vadgama JV. Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis-Antibody Array and Intracellular Signaling Array. PLoS One. 2015; 10(8):e0134948.

View in: PubMed
Hernandez BY, Wilkens LR, Le Marchand L, Horio D, Chong CD, Loo LW. Differences in IGF-axis protein expression and survival among multiethnic breast cancer patients. Cancer Med. 2015 Mar; 4(3):354-62.

View in: PubMed
Sarkissyan M, Mishra DK, Wu Y, Shang X, Sarkissyan S, Vadgama JV. IGF gene polymorphisms and breast cancer in African-American and Hispanic women. Int J Oncol. 2011 Jun; 38(6):1663-73.

View in: PubMed
Verheus M, Maskarinec G, Woolcott CG, Haiman CA, Le Marchand L, Henderson BE, Cheng I, Kolonel LN. IGF1, IGFBP1, and IGFBP3 genes and mammographic density: the Multiethnic Cohort. Int J Cancer. 2010 Sep 01; 127(5):1115-23.

View in: PubMed
Gu F, Schumacher FR, Canzian F, Allen NE, Albanes D, Berg CD, Berndt SI, Boeing H, Bueno-de-Mesquita HB, Buring JE, Chabbert-Buffet N, Chanock SJ, Clavel-Chapelon F, Dumeaux V, Gaziano JM, Giovannucci EL, Haiman CA, Hankinson SE, Hayes RB, Henderson BE, Hunter DJ, Hoover RN, Johansson M, Key TJ, Khaw KT, Kolonel LN, Lagiou P, Lee IM, LeMarchand L, Lund E, Ma J, Onland-Moret NC, Overvad K, Rodriguez L, Sacerdote C, S?nchez MJ, Stampfer MJ, Stattin P, Stram DO, Thomas G, Thun MJ, Tj?nneland A, Trichopoulos D, Tumino R, Virtamo J, Weinstein SJ, Willett WC, Yeager M, Zhang SM, Kaaks R, Riboli E, Ziegler RG, Kraft P. Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer. Cancer Epidemiol Biomarkers Prev. 2010 Nov; 19(11):2877-87.

View in: PubMed
Maskarinec G, Takata Y, Chen Z, Gram IT, Nagata C, Pagano I, Hayashi K, Arendell L, Skeie G, Rinaldi S, Kaaks R. IGF-I and mammographic density in four geographic locations: a pooled analysis. Int J Cancer. 2007 Oct 15; 121(8):1786-92.

View in: PubMed
Hernandez W, Grenade C, Santos ER, Bonilla C, Ahaghotu C, Kittles RA. IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans. Carcinogenesis. 2007 Oct; 28(10):2154-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals